Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

Monday’s trading has closed, but NVAX is being traded in the after-hours session. After-Hours quote »
4.65
Delayed Data
As of 4:14pm ET
 -0.16 / -3.33%
Today’s Change
4.08
Today|||52-Week Range
15.01
-44.58%
Year-to-Date

Today’s Trading

Previous close4.81
Today’s open4.65
Day’s range4.42 - 4.76
Volume15,116,953
Average volume (3 months)7,172,411
Market cap$1.3B
Dividend yield--
Data as of 4:14pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-17.45%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book5.00

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-1.92-6.14%
AXONAxovant Sciences Ltd-1.72-15.32%
HALOHalozyme Therapeutic...-0.58-7.34%
MCRBSeres Therapeutics I...-1.81-7.22%
Data as of 4:02pm ET, 02/08/2016

Financials

Next reporting dateMarch 28, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts

Partner Offers